RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...
In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...
UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.
Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...
Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...
Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis ...
UBS Emerging Markets Equity Opp Fund earns an Average ... The investment seeks to maximize capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets ...
Street Talk understands Hong Kong’s Chow Tai Fook has tapped investment banks UBS and RBC Capital Markets for advice. How much Alinta’s owners are looking to part with is unclear, but Chow Tai ...